Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03398655
Title A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Vascular Biogenics Ltd. operating as VBL Therapeutics
Indications

ovary epithelial cancer

Therapies

Paclitaxel

Paclitaxel + VB-111

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.